Back to mobile site

UPDATE: JPMorgan Downgrades Neurocrine Bio. (NBIX) to Neutral

August 4, 2020 4:17 AM EDT Send to a Friend
(Updated - August 4, 2020 4:58 AM EDT)

(updating comment)JPMorgan analyst Anupam Rama downgraded Neurocrine Bio. (NASDAQ: NBIX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login